Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Uptravi 400 microgram film-coated tablets (Great Britain)

Active Ingredient:
selexipag
Company:  
Janssen-Cilag Ltd (a Johnson & Johnson Company) See contact details
ATC code: 
B01AC27
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Uptravi HCP cover letter

{healthcare_pro_orange} For Healthcare Professionals
Uptravi cover letter for HCPs
{pdf_link}

Uptravi Patient Titration Guide

The patient titration guide will facilitate Uptravi use and explains how the physician calculates the appropriate dose for an individual patient (individualised maintenance dose). It serves as a reminder for the patients (e.g., to contact her/his doctor), and a place to record intake of tablets.
{pdf_link}

Uptravi Titration Guide for HCP

{healthcare_pro_orange} For Healthcare Professionals
This titration guide for healthcare professionals assists with the appropriate dose titration for each patient individually

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Janssen-Cilag Ltd (a Johnson & Johnson Company)
Company image
Address
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone
+44 (0)1494 567 567
Medical Information Fax
+44 (0) 1494 567 445
WWW
https://www.janssen.com/uk/
Fax
+44 (0)1494 567 568
Medical Information Direct Line
+44 (0)800 731 8450
Customer Care direct line
+44 (0)800 731 5550
Medical Information e-mail
[email protected]